Provided by Tiger Trade Technology Pte. Ltd.

ADC Therapeutics SA

1.04
+0.07497.76%
Post-market: 1.040.00000.00%16:19 EDT
Volume:3.92M
Turnover:3.85M
Market Cap:132.13M
PE:-1.57
High:1.05
Open:0.9755
Low:0.9600
Close:0.9651
52wk High:4.98
52wk Low:0.7796
Shares:127.04M
Float Shares:88.56M
Volume Ratio:2.06
T/O Rate:4.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6636
EPS(LYR):-1.1224
ROE:-705.53%
ROA:-19.57%
PB:-0.58
PE(LYR):-0.93

Loading ...

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Lantheus (LNTH)

TIPRANKS
·
Jun 27

Sector Update: Healthcare Stocks Rise Pre-Bell Wednesday

MT Newswires Live
·
Jun 24

ADC Therapeutics Slashes Workforce in Reorganization Focused on Cancer Drug

Dow Jones
·
Jun 24

ADC Therapeutics to reduce workforce by 17% globally

TIPRANKS
·
Jun 24

ADC Therapeutics Plans 17% Workforce Cut in Strategic Reorganization to Back Zynlonta Growth

Reuters
·
Jun 24

ADC Therapeutics - to Reduce Workforce by About 17 Percent

THOMSON REUTERS
·
Jun 24

ADC Therapeutics - Planned Workforce Reduction Expected to Generate Annualized Savings of About $10 Mln

THOMSON REUTERS
·
Jun 24

ADC Therapeutics Announces Strategic Reorganization to Support Zynlonta® Growth Opportunities and Regulatory Priorities

THOMSON REUTERS
·
Jun 24

ADC Therapeutics - Company Expects Cash Runway at Least into 2028

THOMSON REUTERS
·
Jun 24

ADC Therapeutics - Expects One-time Pre-tax Charges of About $3 Mln, Majority in Q2 2026

THOMSON REUTERS
·
Jun 24

ADC Therapeutics - Phase 1B Lotis-7 Data Expected by End of 2026

THOMSON REUTERS
·
Jun 24

ADC Therapeutics - Preparing for Pre-sbla Meeting with FDA in August 2026

THOMSON REUTERS
·
Jun 24

This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday

Benzinga
·
Jun 09

ADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)

Benzinga_recent_news
·
Jun 07

Why Is ADC Therapeutics Stock Falling On Friday?

Benzinga
·
Jun 06

Analysts Are Bullish on These Healthcare Stocks: ADC Therapeutics (ADCT), Bristol-Myers Squibb (BMY)

TIPRANKS
·
Jun 06

ADC Therapeutics Sa : Jefferies Cuts Target Price to $3 From $9

THOMSON REUTERS
·
Jun 05

Top Midday Decliners

MT Newswires Live
·
Jun 05

Top Premarket Decliners

MT Newswires Live
·
Jun 04

Analysts’ Top Healthcare Picks: Fulcrum Therapeutics (FULC), ADC Therapeutics (ADCT)

TIPRANKS
·
Jun 04